Mutabingwa, Theonest K.2020-10-132020-10-132006Duffy, P.E. and Mutabingwa, T.K., 2006. Artemisinin combination therapies. The Lancet, 367(9528), pp.2037-2039.DOI:https://doi.org/10.1016/S0140-6736(06)68900-9http://hdl.handle.net/123456789/649Global mortality from Plasmodium falciparum malaria has always been enormous, and has increased in recent decades as chloroquine-resistant parasites spread worldwide. Alarms were raised further when parasites developed resistance to sulfadoxine-pyrimethamine soon after it was introduced to replace chloroquine in many areas. To protect the few remaining drugs in the malaria armamentarium, combination therapy is now touted, particularly combinations that include artemisinin derivatives, widely known as artemisinin combination therapies (ACTs).enPlasmodium falciparumArtemisininSulfadoxine-pyrimethamineArticle